Document Type : Original Article


1 Zoology Department, Faculty of Life Sciences, Gombe State University, Gombe, Nigeria

2 Microbiology Department, Faculty of Life Sciences, Gombe State University, Gombe, Nigeria


This research aimed to evaluate the larvicidal activity of the lower doses of commercially synthetic Bacillus thuringiensis israelensis (Vectobac 12 Aqueous Solution (12AS)) against the fourth instar larva. One hundred and fifty blood-fed female anopheles mosquitoes were collected from different resting sites from Abuja Quarters in June 2022 using an aspirator and allowed to breed until the first instar larva appeared. The larvae were monitored and fed with 10% yeast until the third instar emerged. 240 healthy third instar larvae were selected and grouped into three treatments containing sixty (60) larvae each and replicated three times. The first, second and third treatments were respectively treated with 0.84, 0.42 and 0.21ml/l of Vectobac 12AS. Each treatment has a control containing twenty (20) larvae. Larval mortality was determined using a glass rod at an interval of 15 minutes for 24 hours. ANOVA was used to statistically analysed differences in the larval mortality between the treatment and probit analysis was used to determine the lethal concentration (LC) and the lethal time (LT). Mortality of 1(6.7%) and 3(5.0%) were observed in the first treatment (0.84ml/l) after 15 and 30minute of exposure respectively. The highest mortality of 60(100%) was observed in all the treatments after 24 hours of exposure. Statistically, there was no significant difference (F=0.081, P> 0.05). 2.35 ml/l, 5.54 ml/l and 8.15 ml/l was determined to be LC50, LC90 and LC99 respectively and LT50, LT90 and LT99 were found to be, 1809.29min and 2451.34min respectively. Conclusively vectobac 12AS has demonstrated a high level of efficacy as it revealed 100% larval mortality even at a lower recommended dose. Further research should be carried out to study the impact of other biological and environmental factors on the efficacy of vectobac 12AS.

Graphical Abstract

In vitro assessment of the Larvicidal activity of Bacillus thuringiensis israelensis (Vectobac 12AS formulation) on Anopheles mosquito larvae


Main Subjects

Selected author of this article by journal

ِDr. Rejoice Asher
Gombe State University

Google Scholar

Open Access

This article is licensed under a CC BY License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit:


Publisher’s Note

CMBR journal remains neutral with regard to jurisdictional claims in published maps and institutional afflictions.


Letters to Editor

Given that CMBR Journal's policy in accepting articles will be strict and will do its best to ensure that in addition to having the highest quality published articles, the published articles should have the least similarity (maximum 18%). Also, all the figures and tables in the article must be original and the copyright permission of images must be prepared by authors. However, some articles may have flaws and have passed the journal filter, which dear authors may find fault with. Therefore, the editor of the journal asks the authors, if they see an error in the published articles of the journal, to email the article information along with the documents to the journal office.

CMBR Journal welcomes letters to the editor ([email protected]) for the post-publication discussions and corrections which allows debate post publication on its site, through the Letters to Editor. Critical letters can be sent to the journal editor as soon as the article is online. Following points are to be considering before sending the letters (comments) to the editor.

[1] Letters that include statements of statistics, facts, research, or theories should include appropriate references, although more than three are discouraged.
[2] Letters that are personal attacks on an author rather than thoughtful criticism of the author’s ideas will not be considered for publication.
[3] There is no limit to the number of words in a letter.
[4] Letter writers should include a statement at the beginning of the letter stating that it is being submitted either for publication or not.

[5] Anonymous letters will not be considered.
[6] Letter writers must include Name, Email Address, Affiliation, mobile phone number, and Comments

[7] Letters will be answered as soon as possible

  1. Sanabria-Jimenez S, Lozano LC (2022) Larvicidal activity of Bacillus thuringiensis subsp. israelensis (Bacillaceae) and plant extracts for the biological control of Aedes aegypti (Culicidae). Artículo Biol 44 (117): 1-8. doi:
  2. Bamou R, Mayi MPA, Djiappi-Tchamen B, Nana-Ndjangwo SM, Nchoutpouen E, Cornel AJ, Awono-Ambene P, Parola P, Tchuinkam T, Antonio-Nkondjio C (2021) An update on the mosquito fauna and mosquito-borne diseases distribution in Cameroon. Parasites & vectors 14 (1): 1-15. doi:
  3. Brühl CA, Després L, Frör O, Patil CD, Poulin B, Tetreau G, Allgeier S (2020) Environmental and socioeconomic effects of mosquito control in Europe using the biocide Bacillus thuringiensis subsp. israelensis (Bti). Science of The Total Environment 724: 137800. doi:
  4. Demissew A, Balkew M, Girma M (2016) Larvicidal activity of chinaberry, neem and Bti to an insecticide resistant population of Anopheles arabiensis from Tolay, South West Ethiopia. Asian Pac J Trop Biomed 6 (7): 554-561. doi:
  5. Nartey R, Owusu-Dabo E, Kruppa T, Baffour-Awuah S, Annan A, Oppong S, Becker N, Obiri-Danso K (2013) Use of Bacillus thuringiensis var israelensis as a viable option in an Integrated Malaria Vector Control Programme in the Kumasi Metropolis, Ghana. Parasit Vectors 6 (1): 1-10. doi:
  6. Koskella J, Stotzky G (2002) Larvicidal toxins from Bacillus thuringiensis subspp. kurstaki, morrisoni (strain tenebrionis), and israelensis have no microbicidal or microbiostatic activity against selected bacteria, fungi, and algae in vitro. Canadian Journal of Microbiology 48 (3): 262-267. doi:
  7. Ingabire CM, Hakizimana E, Rulisa A, Kateera F, Van Den Borne B, Muvunyi CM, Mutesa L, Van Vugt M, Koenraadt CJ, Takken W (2017) Community-based biological control of malaria mosquitoes using Bacillus thuringiensis var. israelensis (Bti) in Rwanda: community awareness, acceptance and participation. Malaria Journal 16: 1-13. doi:
  8. Vasanthakumari S (2019) Soft skills and its application in work place. World J Adv Res Rev 3 (2): 066-072. doi:
  9. Milugo TK, Tchouassi DP, Kavishe RA, Dinglasan RR, Torto B (2021) Naturally occurring compounds with larvicidal activity against malaria mosquitoes. Front Trop Dis 2: 718804. doi:
  10. Edmond K, Aurelie FDG, Nadège S-C, Roland B, Landre D-D, Abdou T, Serges D, Flobert N, Parfait A-A, Sinclair WC (2021) Efficacy of the Microbial Larvicide VectoMax® G against Anopheles gambiae sl and Culex spp. Larvae under Laboratory and Open Field Trial Experiments in the City of Yaoundé, Cameroon. Adv Entomolgy 10 (1): 34-51. doi:
  11. Das BP, Deobhankar K (2022) Management of Insect Borne Human Diseases–A Case Study on Novel Bio-Larvicide for Mosquito Borne Diseases Including Dengue. Indian Journal of Entomology 84 ((Special Issue (December)): 61-76. doi:
  12. Soares-da-Silva J, Queirós SG, de Aguiar JS, Viana JL, Neta MdRAV, da Silva MC, Pinheiro VCS, Polanczyk RA, Carvalho-Zilse GA, Tadei WP (2017) Molecular characterization of the gene profile of Bacillus thuringiensis Berliner isolated from Brazilian ecosystems and showing pathogenic activity against mosquito larvae of medical importance. Acta Tropica 176: 197-205. doi:
  13. Valtierra-de-Luis D, Villanueva M, Berry C, Caballero P (2020) Potential for Bacillus thuringiensis and other bacterial toxins as biological control agents to combat dipteran pests of medical and agronomic importance. Toxins 12 (12): 773. doi:
  14. Fazeli-Nasab B, Rahmani AF, Valizadeh M, Khajeh H, Beigomi M (2021) Evaluation of Antimicrobial Activity of Some Medicinal Plants on Human Standard Bacteria and Candida albicans. Gene Cell Tissue 8 (3): e113092. doi:
  15. Fazeli-Nasab B, Shahraki-Mojahed L, Hassanzadeh MA, Bidarnamani F (2022) Investigation of antimicrobial activity of medicinal plant extracts on Bacillus cereus isolated from soil. Gene, Cell and Tissue 9 (1): e115133. doi:
  16. Guerrero M GG (2023) Sporulation, Structure Assembly, and Germination in the Soil Bacterium Bacillus thuringiensis: Survival and Success in the Environment and the Insect Host. Microbiology Research 14 (2): 466-491. doi:
  17. Tanapongpipat S, Luxananil P, Promdonkoy B, Chewawiwat N, Audtho M, Panyim S (2003) A plasmid encoding a combination of mosquito-larvicidal genes from Bacillus thuringiensis subsp. israelensis and Bacillus sphaericus confers toxicity against a broad range of mosquito larvae when expressed in Gram-negative bacteria. FEMS Microbiol Lett 228 (2): 259-263. doi:
  18. Dambach P, Louis VR, Kaiser A, Ouedraogo S, Sié A, Sauerborn R, Becker N (2014) Efficacy of Bacillus thuringiensis var. israelensis against malaria mosquitoes in northwestern Burkina Faso. Parasites & vectors 7: 1-8. doi:
  19. Elleuch J, Zribi Zghal R, Lacoix MN, Chandre F, Tounsi S, Jaoua S (2015) Evidence of two mechanisms involved in Bacillus thuringiensis israelensis decreased toxicity against mosquito larvae: Genome dynamic and toxins stability. Microbiological Research 176: 48-54. doi:
  20. Poulin B, Lefebvre G, Hilaire S, Després L (2022) Long-term persistence and recycling of Bacillus thuringiensis israelensis spores in wetlands sprayed for mosquito control. Ecotoxicology and Environmental Safety 243: 114004. doi:
  21. Almeida JS, Mohanty AK, Kerkar S, Hoti SL, Kumar A (2020) Current status and future prospects of bacilli-based vector control. Asian Pac J Trop Med 13 (12): 525-534. doi:
  22. Katak RM, Rocha EM, Oliveira JC, Muniz VA, Oliveira MR, Ferreira FA, Silva WR, Roque RA, de Souza AQ, Souza-Neto JA (2021) Larvicidal activities against Aedes aegypti of supernatant and pellet fractions from cultured Bacillus spp. isolated from Amazonian microenvironments. Tropical Medicine and Infectious Disease 6 (2): 104. doi:
  23. Sugai M, Fujiwara T, Akiyama T, Ohara M, Komatsuzawa H, Inoue S, Suginaka H (1997) Purification and molecular characterization of glycylglycine endopeptidase produced by Staphylococcus capitis EPK1. Journal of bacteriology 179 (4): 1193-1202. doi:
  24. Ndiath MO, Mazenot C, Gaye A, Konate L, Bouganali C, Faye O, Sokhna C, Trape J-F (2011) Methods to collect Anopheles mosquitoes and evaluate malaria transmission: a comparative study in two villages in Senegal. Malaria journal 10: 1-7. doi:
  25. Russell TL, Brown MD, Purdie DM, Ryan PA, Kay BH (2003) Efficacy of VectoBac (Bacillus thuringiensis variety israelensis) formulations for mosquito control in Australia. Journal of Economic Entomology 96 (6): 1786-1791. doi:
  26. Valtierra-de-Luis D, Villanueva M, Lai L, Williams T, Caballero P (2020) Potential of Cry10Aa and Cyt2Ba, two minority δ-endotoxins produced by Bacillus thuringiensis ser. israelensis, for the control of Aedes aegypti larvae. Toxins 12 (6): 355. doi:
  27. Gowelo S, Chirombo J, Spitzen J, Koenraadt CJ, Mzilahowa T, Van Den Berg H, Takken W, McCann R (2020) Effects of larval exposure to sublethal doses of Bacillus thuringiensis var. israelensis on body size, oviposition and survival of adult Anopheles coluzzii mosquitoes. Parasites & vectors 13: 1-8. doi:
  28. Galán-Wong LJ, Gamiño-Hernández R, Fernández-Chapa D, García-Díaz G, La Garza-Ramos D, Myriam A, Guajardo-Barbosa C, Luna-Olvera HA (2017) Persistence of toxic activity of fermentation extracts from Bacillus thuringiensis var. israelensis after more than three decades of storage. International Journal of Microbiology 2017: Article ID 5402748. doi: